1-44830004-A-G

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_003738.5(PTCH2):​c.840T>C​(p.Ser280Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00629 in 1,614,010 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0052 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0064 ( 52 hom. )

Consequence

PTCH2
NM_003738.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -3.32

Publications

3 publications found
Variant links:
Genes affected
PTCH2 (HGNC:9586): (patched 2) This gene encodes a transmembrane receptor of the patched gene family. The encoded protein may function as a tumor suppressor in the hedgehog signaling pathway. Alterations in this gene have been associated with nevoid basal cell carcinoma syndrome, basal cell carcinoma, medulloblastoma, and susceptibility to congenital macrostomia. Alternatively spliced transcript variants have been described.[provided by RefSeq, Oct 2009]
PTCH2 Gene-Disease associations (from GenCC):
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD, Unknown Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • commissural facial cleft
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 1-44830004-A-G is Benign according to our data. Variant chr1-44830004-A-G is described in ClinVar as Benign. ClinVar VariationId is 239562.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.32 with no splicing effect.
BS2
High AC in GnomAd4 at 788 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTCH2NM_003738.5 linkc.840T>C p.Ser280Ser synonymous_variant Exon 7 of 22 ENST00000372192.4 NP_003729.3
PTCH2NM_001166292.2 linkc.840T>C p.Ser280Ser synonymous_variant Exon 7 of 23 NP_001159764.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTCH2ENST00000372192.4 linkc.840T>C p.Ser280Ser synonymous_variant Exon 7 of 22 1 NM_003738.5 ENSP00000361266.3
PTCH2ENST00000447098.7 linkc.840T>C p.Ser280Ser synonymous_variant Exon 7 of 23 1 ENSP00000389703.2

Frequencies

GnomAD3 genomes
AF:
0.00518
AC:
788
AN:
152082
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000942
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00255
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00676
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.0172
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00707
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00535
AC:
1343
AN:
251018
AF XY:
0.00509
show subpopulations
Gnomad AFR exome
AF:
0.000866
Gnomad AMR exome
AF:
0.00179
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00250
Gnomad FIN exome
AF:
0.0182
Gnomad NFE exome
AF:
0.00693
Gnomad OTH exome
AF:
0.00506
GnomAD4 exome
AF:
0.00640
AC:
9362
AN:
1461810
Hom.:
52
Cov.:
32
AF XY:
0.00632
AC XY:
4595
AN XY:
727198
show subpopulations
African (AFR)
AF:
0.000538
AC:
18
AN:
33480
American (AMR)
AF:
0.00235
AC:
105
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26134
East Asian (EAS)
AF:
0.0133
AC:
527
AN:
39700
South Asian (SAS)
AF:
0.000487
AC:
42
AN:
86236
European-Finnish (FIN)
AF:
0.0184
AC:
983
AN:
53410
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5766
European-Non Finnish (NFE)
AF:
0.00666
AC:
7403
AN:
1111974
Other (OTH)
AF:
0.00457
AC:
276
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
549
1098
1646
2195
2744
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
268
536
804
1072
1340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00518
AC:
788
AN:
152200
Hom.:
4
Cov.:
33
AF XY:
0.00547
AC XY:
407
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.000939
AC:
39
AN:
41518
American (AMR)
AF:
0.00255
AC:
39
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00677
AC:
35
AN:
5168
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4824
European-Finnish (FIN)
AF:
0.0172
AC:
182
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00707
AC:
481
AN:
68010
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
41
81
122
162
203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00576
Hom.:
6
Bravo
AF:
0.00372
Asia WGS
AF:
0.00606
AC:
21
AN:
3478
EpiCase
AF:
0.00425
EpiControl
AF:
0.00439

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PTCH2: BP4, BP7, BS1, BS2

not specified Benign:1
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Basal cell carcinoma, susceptibility to, 1 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gorlin syndrome Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Basal cell nevus syndrome 1 Benign:1
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.080
DANN
Benign
0.22
PhyloP100
-3.3
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147627670; hg19: chr1-45295676; API